In NSCLC, USP28 has been identified as a potential driver of oncogenesis, contributing to tumor growth and progression through the stabilization of specific substrates involved in cell proliferation and survival pathways [18, 19]. Here, USP28 is linked to non-small cell lung carcinoma.